Skip to content


Ambien, Ambien Cr, Edluar, Intermezzo, Tovalt Odt, Zolpimist, Simbrinza (tartrate) is a small molecule pharmaceutical. Tartrate was first approved as Ambien on 1992-12-16. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. Cafergot's patent is valid until 2032-08-07 (FDA).
Trade Name Simbrinza
Common Name Tartrate
Indication ocular hypertension, open-angle glaucoma
Drug Class
Get full access now